Indian Journal of Palliative Care is a premier peer-reviewed publication dedicated to advancing the field of palliative care within the broader domains of health policy and public health. Published by SCIENTIFIC SCHOLAR LLC in India since 2003, this Open Access journal is committed to providing a platform for innovative research and practices that promote quality of life for patients with life-limiting illnesses. With a focus on health policy and environmental and occupational health, the journal holds a respected position in the Q3 quartile for both categories, reflecting its significant contributions to scholarly discourse. Ranked #393 in Public Health and #185 in Health Policy according to Scopus, it serves as an essential resource for researchers, professionals, and students seeking to deepen their understanding of palliative care and its implications within public policy and health frameworks. Through its rigorous editorial standards and broad accessibility, the Indian Journal of Palliative Care plays a vital role in shaping effective solutions and policies that aim to enhance patient care and well-being.

Journal of Geriatric Oncology, published by Elsevier, stands at the intersection of geriatric medicine and oncology, addressing the unique needs and challenges of cancer management in older adults. Since its inception in 2010, this esteemed journal has played a pivotal role in advancing research and clinical practices, aiming to improve the quality of life and treatment outcomes for elderly cancer patients. With its impressive categorization in the 2023 Q2 quartile for both Geriatrics and Gerontology and Oncology, the journal demonstrates a noteworthy impact within its fields, ranking #153 out of 404 in Medicine – Oncology and #45 out of 116 in Medicine – Geriatrics and Gerontology. Researchers and healthcare professionals are encouraged to access critical insights through its rigorous peer-reviewed articles, which offer cutting-edge research findings and clinical applications. As the field continues to evolve, the Journal of Geriatric Oncology remains a vital resource for those dedicated to fostering innovation in geriatric oncology.

Cancers is a leading peer-reviewed journal published by MDPI, dedicated to advancing the field of oncology and cancer research. Established in 2009 and based in Switzerland, this Open Access journal provides a platform for the rapid dissemination of high-quality research findings, reviews, and clinical studies related to all aspects of cancer biology and treatment. With an impressive impact factor and recognized as Q1 in Oncology and Q2 in Cancer Research for 2023, Cancers strives to foster a collaborative environment among researchers, healthcare professionals, and students seeking to deepen their knowledge and understanding of cancer. The journal’s commitment to accessibility and its broad scope make it an invaluable resource for anyone passionate about combating cancer and improving patient outcomes. For more information and to access its diverse publications, visit the journal’s website.

ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.

Asian Oncology Nursing is a pivotal journal dedicated to advancing the field of oncology nursing across the Asian continent and beyond. Published by the esteemed Korean Oncology Nursing Society, this journal serves as a platform for researchers, clinicians, and educators to disseminate groundbreaking findings and innovative practices in cancer care and nursing. With an ISSN of 2287-2434 and E-ISSN 2093-7776, it is committed to enhancing the knowledge and skills of oncology nursing professionals, thereby improving patient outcomes. Although currently not operating as an open-access platform, the journal emphasizes the significance of bridging the research gap in oncology nursing, fostering collaboration among professionals in the field. Given the increasing importance of culturally competent care in oncology, Asian Oncology Nursing positions itself as an essential resource for those who strive to elevate standards of care and educate future generations of oncology nurses.

Lung Cancer Management, published by FUTURE MEDICINE LTD, is a premier academic journal dedicated to the evolving field of oncology and respiratory medicine. With an ISSN of 1758-1966 and an E-ISSN of 1758-1974, this journal offers a platform for the dissemination of cutting-edge research, clinical studies, and expert reviews, all focusing on the latest advances in lung cancer treatment and management. Despite being a relatively new entry since its inception in 2014 and achieving its converged years from 2020 to 2024, it has already established itself in the Q3 quartile for both oncology and pulmonary and respiratory medicine as of 2023, according to category quartiles rankings. With a Scopus ranking of #98 in the category of Pulmonary and Respiratory Medicine and #266 in Oncology, the journal reflects a commitment to quality and relevance in its content. Although it does not offer open access, it remains a crucial resource for researchers, clinicians, and students seeking to stay informed about the latest developments and practical approaches in lung cancer management. The journal is accessible from its base in the United Kingdom, at UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ensuring that it caters to a global audience eager to explore and contribute to this vital field of medicine.

BMJ Supportive & Palliative Care is a leading academic journal dedicated to advancing the field of supportive and palliative care, published by the esteemed BMJ PUBLISHING GROUP in the United Kingdom. With an ISSN of 2045-435X and an E-ISSN of 2045-4368, this journal showcases high-quality, peer-reviewed articles that cater to a diverse audience, including healthcare professionals, researchers, and students. Notably, it holds a commendable impact factor, reflecting its credibility and influence within the academic community. As of 2023, the journal ranks in the top quartile (Q1) for Medical and Surgical Nursing and holds prestigious positions in the Q2 category for Medicine (miscellaneous) and Oncology (nursing), demonstrating its significance in multiple disciplines. Research published in this journal aims to enhance patient-centered care practices and improve health outcomes, making it an invaluable resource for innovative studies and discussions in the field. With a commitment to open access principles, BMJ Supportive & Palliative Care serves as a pivotal platform for disseminating knowledge and supporting the ongoing professional development of its readership.

The International Journal of Cancer Management is a distinguished publication dedicated to advancing knowledge and research in the fields of cancer management, oncology, pharmacology, and radiology. Published by BRIEFLAND in the Netherlands, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in cancer care and treatment strategies. With an ISSN of 2538-4422 and an E-ISSN of 2538-497X, the journal features a range of peer-reviewed articles that cover diverse aspects of cancer management, reflecting its commitment to high-quality, impactful research. The journal ranks in the Q4 category for Cancer Research and Oncology and Q3 for both Pharmacology and Surgery in 2023, signifying its growing influence in the scientific community. Through its open access format, the International Journal of Cancer Management ensures that critical research findings are accessible to all, promoting collaboration and innovation in the battle against cancer. Researchers looking to share their findings or learn more about current trends will find this journal an invaluable addition to their professional toolkit.

The Lancet Oncology is a premier peer-reviewed journal published by Elsevier Science Inc., recognized as a leading authority in the field of oncology. With an ISSN of 1470-2045 and E-ISSN 1474-5488, this esteemed journal boasts an impressive 2023 impact factor placing it in the Q1 category of oncology—reflecting its role as a critical resource for cutting-edge research. The journal publishes high-quality articles covering novel scientific discoveries, clinical advancements, and public health issues related to cancer treatment and prevention. It is ranked #5 out of 404 in the Scopus Medicine _ Oncology category, demonstrating its influence and relevance in the field, with an outstanding rank in the 98th percentile. Operating from its base in the United Kingdom, The Lancet Oncology spans a comprehensive timeframe from 2000 to 2024, making it a vital repository of oncology literature. Although it does not primarily operate on an open-access model, its significant subscription base ensures that a wealth of knowledge is accessible to researchers, professionals, and students alike, fostering a profound understanding and advancement in oncology.

Medycyna Paliatywna-Palliative Medicine is a vital academic journal dedicated to advancing the field of palliative care, published by TERMEDIA PUBLISHING HOUSE LTD. With its ISSN 2081-0016 and E-ISSN 2081-2833, this journal serves as a reputable source of high-quality research and compelling insights for scholars, healthcare professionals, and students committed to improving the quality of life for patients with serious illnesses. Although it does not currently offer Open Access, Medycyna Paliatywna ensures that articles published within its pages undergo rigorous peer review, reflecting the highest standards in medical research. The journal aims to contribute to the ongoing dialogue in palliative medicine, encouraging innovative practices, sharing evidence-based strategies, and fostering collaboration among healthcare providers. By disseminating important findings and clinical insights, Medycyna Paliatywna plays a crucial role in shaping the future direction of palliative care, making it an essential resource for anyone involved in this critical field.